About Tethis
Tethis is a company based in Milan (Italy) founded in 2004. It operates as a HealthTech. Tethis has raised $15.33 million across 5 funding rounds from investors including European Union, ENEA Tech e Biomedical and unknown. Tethis offers products and services including Liquid Biopsy Solution. Tethis operates in a competitive market with competitors including GRAIL, Color, Biological Dynamics, Earli and Biovica, among others.
- Headquarter Milan, Italy
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tethis S.P.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.33 M (USD)
in 5 rounds
-
Latest Funding Round
$15.33 M (USD), Private Equity Round
Jan 14, 2025
-
Investors
European Union
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tethis
Tethis offers a comprehensive portfolio of products and services, including Liquid Biopsy Solution. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Liquid biopsy is developed for early cancer detection.
Funding Insights of Tethis
Tethis has successfully raised a total of $15.33M across 5 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $15.33 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Private Equity Round — $15.3M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Private Equity Round - Tethis | Valuation |
investors |
|
| Aug, 2018 | Amount | Grant - Tethis | Valuation |
investors |
|
| May, 2018 | Amount | Grant - Tethis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tethis
Tethis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, ENEA Tech e Biomedical and unknown. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tethis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tethis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tethis Comparisons
Competitors of Tethis
Tethis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Color, Biological Dynamics, Earli and Biovica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Cancer care is delivered through a virtual clinic by Color.
|
|
| domain | founded_year | HQ Location |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| domain | founded_year | HQ Location |
Early cancer detection tests are developed using synthetic biomarkers.
|
|
| domain | founded_year | HQ Location |
Tumor response to cancer therapies is monitored via specialized assays.
|
|
| domain | founded_year | HQ Location |
Developer of nucleic acid detection and quantification systems
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tethis
Frequently Asked Questions about Tethis
When was Tethis founded?
Tethis was founded in 2004 and raised its 1st funding round 6 years after it was founded.
Where is Tethis located?
Tethis is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Is Tethis a funded company?
Tethis is a funded company, having raised a total of $15.33M across 5 funding rounds to date. The company's 1st funding round was a Grant of $59.96K, raised on May 26, 2010.
What does Tethis do?
Tethis is engaged in the development of liquid biopsy solutions for early cancer detection and improved treatment guidance. The company operates in the healthcare sector, specifically targeting oncology diagnostics. Innovative approaches are utilized to preserve sample integrity through automated and standardized processing. Collaborations with institutions like Sheba Medical Center and Weill Cornell Medicine are maintained to enhance AI-powered diagnostics and cellular residual disease monitoring in cancers such as rectal and early-stage breast cancer.
What products or services does Tethis offer?
Tethis offers Liquid Biopsy Solution.
Who are Tethis's investors?
Tethis has 4 investors. Key investors include European Union, ENEA Tech e Biomedical, unknown, and EIC Fund.